Nemours Name Change Reflects Bold Strategic Direction to Redefine Children s Health
New visual identity represents transformative vision for Nemours future
News provided by
Share this article
Share this article
JACKSONVILLE, Fla., May 12, 2021 /PRNewswire/ Nemours Children s Health System announced today it will be evolving its name and introducing its new brand mark to better reflect the organization s bold vision of redefining children s health. The new name and mark were shared with Nemours associates during a virtual Founder s Day event commemorating Alfred I. duPont s philanthropic legacy supporting children s health and marking the launch of a new five-year strategic plan.
R.L. Moss, MD, President and CEO Nemours Children s Health
Researchers identify new immunotherapy treatment target for acute myeloid leukemia in children
Researchers have identified a gene expressed in children with acute myeloid leukemia (AML) that could serve as a new immunotherapy treatment target, according to a new study published today in
Blood Advances, a journal of the American Society of Hematology. The study, co-authored by researchers with Nemours Children s Health System, outlines the process and potential path for new immunotherapy drugs that improve survival and reduce treatment-related toxicity in children with AML.
Leukemia is the most common cancer in children and teens, and AML accounts for nearly one-fourth of those cases. AML is a fast-growing cancer that typically starts in immature bone marrow cells.
E-Mail
ORLANDO, Fla. (May 3, 2021) - Researchers have identified a gene expressed in children with acute myeloid leukemia (AML) that could serve as a new immunotherapy treatment target, according to a new study published today in
Blood Advances, a journal of the American Society of Hematology. The study, co-authored by researchers with Nemours Children s Health System, outlines the process and potential path for new immunotherapy drugs that improve survival and reduce treatment-related toxicity in children with AML.
Leukemia is the most common cancer in children and teens, and AML accounts for nearly one-fourth of those cases. AML is a fast-growing cancer that typically starts in immature bone marrow cells.
Social, economic, and demographic factors that can influence health did not affect families' acceptance of telehealth for their children's cardiac care during the COVID-19 pandemic, according to a study presented at the Pediatric Academic Society 2021 Virtual Meeting.
E-Mail
WILMINGTON, Del. (April 30, 2021) - Social, economic, and demographic factors that can influence health did not affect families acceptance of telehealth for their children s cardiac care during the COVID-19 pandemic, according to a study presented at the Pediatric Academic Society 2021 Virtual Meeting. The study, by research team members at the Nemours Children s Health System, suggests that telehealth is a feasible tool for families regardless of household income, language, or insurance type. When we saw that the use of telehealth would be necessary for maintaining children s cardiac care during COVID, we worried that some of our families would face barriers in using it, said lead author Carissa M. Baker-Smith, MD, MPH, director of Preventive Cardiology at Nemours. We saw that these factors were not a barrier in families choice to use telehealth and in fact may have been a welcome option.